30 | Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
12/2020
-
09/2002 |
16 | Pharmaceutical PreparationsIBA
01/2022
-
05/2011 |
12 | Immunoconjugates (Immunoconjugate)IBA
01/2022
-
01/2015 |
9 | Monoclonal AntibodiesIBA
04/2016
-
06/2006 |
6 | RON proteinIBA
11/2020
-
11/2002 |
6 | Biological ProductsIBA
01/2019
-
09/2002 |
5 | Tyrosine Kinase InhibitorsIBA
07/2020
-
05/2013 |
5 | N- (4- (2- amino- 3- chloropyridin- 4- yloxy)- 3- fluorophenyl)- 4- ethoxy- 1- (4- fluorophenyl)- 2- oxo- 1,2- dihydropyridine- 3- carboxamideIBA
07/2020
-
05/2013 |
5 | Small Interfering RNA (siRNA)IBA
05/2013
-
11/2004 |
4 | Proteins (Proteins, Gene)FDA Link
10/2020
-
11/2004 |
4 | tyrosine receptor (receptor, tyrosine)IBA
09/2020
-
11/2004 |
4 | Phosphotransferases (Kinase)IBA
09/2020
-
11/2004 |
3 | Biomarkers (Surrogate Marker)IBA
10/2020
-
12/2015 |
3 | Messenger RNA (mRNA)IBA
10/2020
-
12/2012 |
3 | RNA (Ribonucleic Acid)IBA
10/2020
-
11/2004 |
3 | AntibodiesIBA
01/2019
-
08/2010 |
3 | Therapeutic UsesIBA
10/2014
-
01/2012 |
2 | Proto-Oncogene Proteins c-metIBA
01/2022
-
01/2021 |
2 | Dihydrotachysterol (AT 10)IBA
01/2022
-
12/2018 |
2 | capmatinibIBA
07/2020
-
01/2019 |
2 | ARQ 197IBA
07/2020
-
01/2019 |
2 | 5- ((2,6- dichlorobenzyl)sulfonyl)- 3- ((3,5- dimethyl- 4- ((2- (pyrrolidin- 1- ylmethyl)pyrrolidin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- 1,3- dihydro- 2H- indol- 2- oneIBA
01/2019
-
07/2013 |
2 | 6- methoxy- 1- (naphthalen- 1- yl)- 9H- pyrido(3,4- b)indoleIBA
05/2015
-
10/2014 |
2 | (5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA
05/2014
-
01/2014 |
2 | Aurora Kinase BIBA
01/2014
-
05/2013 |
2 | LigandsIBA
07/2013
-
06/2010 |
2 | Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
07/2013
-
09/2010 |
2 | macrophage stimulating proteinIBA
07/2013
-
06/2010 |
2 | GinsenosidesIBA
01/2012
-
01/2012 |
2 | Doxorubicin (Adriamycin)FDA LinkGeneric
05/2011
-
04/2010 |
2 | Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
11/2007
-
07/2007 |
2 | beta CateninIBA
07/2005
-
11/2004 |
1 | DuocarmycinsIBA
01/2021 |
1 | Bispecific AntibodiesIBA
12/2020 |
1 | Staphylococcal Protein A (Protein A)IBA
12/2020 |
1 | B7-H1 AntigenIBA
11/2020 |
1 | N-methyladenosineIBA
10/2020 |
1 | LuciferasesIBA
10/2020 |
1 | MethyltransferasesIBA
01/2020 |
1 | Cytotoxins (Cytolysins)IBA
01/2020 |
1 | plexinIBA
01/2019 |
1 | IntegrinsIBA
01/2019 |
1 | Semaphorins (Semaphorin)IBA
01/2019 |
1 | Membrane Proteins (Integral Membrane Proteins)IBA
01/2018 |
1 | Sulfides (Thioethers)IBA
04/2016 |
1 | GemcitabineFDA Link
01/2016 |
1 | CateninsIBA
01/2015 |
1 | TCF Transcription FactorsIBA
01/2015 |
1 | Maytansine (Maitansine)IBA
12/2014 |
1 | indoleIBA
10/2014 |
1 | Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
10/2014 |
1 | sepantroniumIBA
05/2014 |
1 | DNA (Deoxyribonucleic Acid)IBA
05/2014 |
1 | SurvivinIBA
05/2014 |
1 | A-Form DNA (A-DNA)IBA
05/2014 |
1 | GalactosidasesIBA
05/2014 |
1 | Oncogene Proteins (Oncogene Protein)IBA
09/2013 |
1 | 7- (benzylamino)- 1,3,4,8- tetrahydropyrrolo(4,3,2- de)quinolin- 8(1H)- oneIBA
07/2013 |
1 | iminoquinoneIBA
07/2013 |
1 | TubulinIBA
05/2013 |
1 | Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
12/2012 |
1 | Vascular Endothelial Growth Factor CIBA
12/2012 |
1 | Vascular Endothelial Growth Factor DIBA
12/2012 |
1 | 7- (4- fluorobenzylamino)- 1,3,4,8- tetrahydropyrrolo(4,3,2- de)quinolin- 8(1H)- oneIBA
05/2012 |
1 | CyclinsIBA
01/2012 |
1 | 25-methoxylprotopanaxadiolIBA
01/2012 |
1 | SulfonamidesIBA
01/2012 |
1 | Antineoplastic Agents (Antineoplastics)IBA
01/2012 |
1 | CaspasesIBA
01/2012 |
1 | AMP-Activated Protein KinasesIBA
01/2012 |
1 | Death Domain ReceptorsIBA
01/2012 |
1 | Harmine (Telepathine)IBA
01/2012 |
1 | Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2012 |
1 | Protein Kinases (Protein Kinase)IBA
01/2012 |
1 | SaponinsIBA
01/2012 |